Adagio Medical Announces First-In-Human Use and Initiation of Multi-Center Study of Ultra-Low Temperature Cryoablation for Treatment of Recurrent Ventricular Tachycardia, Opening New Possibilities for High-Risk PatientsMarv Kogan2021-07-08T09:44:37-07:00July 6th, 2021|Read More
Adagio Medical Raises $42.5 Million In Series E FinancingMarv Kogan2020-11-17T07:53:44-08:00November 17th, 2020|Read More
Adagio Medical, Inc., reports pre-clinical effectiveness combining their existing ultra-low temperature cryoablation catheter with Pulsed Field Ablation (PFA) in a single Pulsed Field Cryoablation (PFCA) catheterMarv Kogan2020-08-04T08:40:44-07:00August 3rd, 2020|Read More
Adagio Medical Receives CE Mark Approval for its iCLAS™ Cryoablation System and Prepares for European Commercial LaunchMarv Kogan2020-06-02T10:30:47-07:00June 1st, 2020|Read More
Adagio Medical Announces First Patient Enrollment in its iCLAS™ U.S. IDE Clinical Trial Evaluating Ultra-Low Temperature Cryoablation for Persistent Atrial FibrillationMarv Kogan2019-12-17T14:03:00-08:00December 16th, 2019|Read More
Adagio Medical Announces US FDA Investigational Device Exemption Approval With Conditions To Conduct A Clinical Study For Treatment Of Persistent Atrial Fibrillation Using The Ultra-Low Temperature Cryoablation SystemMarv Kogan2019-08-20T00:30:21-07:00August 19th, 2019|Read More
Adagio Medical: Lowering Temperatures, Raising BarsMarv Kogan2018-12-28T10:49:32-08:00December 28th, 2018|Read More
Cryoablation Market Could Be About to ChangeMarv Kogan2018-11-12T14:47:16-08:00October 23rd, 2018|Read More
Tom De Potter – First-in-human results of ultra-low-temperature continuous ablation (Video)Marv Kogan2018-04-24T11:49:26-07:00April 9th, 2018|Read More
Ultra-Low-Temp Catheter Heats Up Cryoablation for AFMarv Kogan2018-04-24T15:03:03-07:00April 3rd, 2018|Read More
